Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06948591

BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures

Real World Evaluation of the Safety and Effectiveness of BioBrace® Augmentation in Anterior Cruciate Ligament (ACL) Reconstruction Procedures

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
CONMED Corporation · Industry
Sex
All
Age
14 Years – 70 Years
Healthy volunteers

Summary

This research study will evaluate mid-term clinical safety and performance outcomes of the BioBrace® Reinforced Implant when used to augment a tissue graft during anterior cruciate ligament (ACL) reconstruction.

Detailed description

This is a multi-center, single arm, open label registry investigating anterior cruciate ligament reconstruction (ACLR) procedures where the tissue graft is augmented with BioBrace®. Subjects meeting the inclusion/exclusion criteria will be enrolled retrospectively or prospectively. Clinical evaluations will be conducted at baseline (pre-operatively) and at 6 months, 1-, 2-, and 3-years post-operatively using various patient-reported outcome measures to assess pain, function, return to activity, and safety post-surgery.

Conditions

Interventions

TypeNameDescription
DEVICEAnterior cruciate ligament reconstruction with BioBrace® augmentationAn arthroscopic anterior cruciate ligament reconstruction (ACLR) will be performed and the tissue graft will be augmented with the BioBrace® Reinforced Implant. BioBrace® is intended for use in surgical procedures for reinforcement of soft tissue where weakness exists. It is a bioresorbable, biocomposite scaffold composed of a highly porous collagen sponge and reinforced with poly-L-lactic-acid (PLLA). When used in ACLRs, it is sutured alongside the tissue graft to augment and reinforce the graft construct. BioBrace® is designed to mechanically and biologically augment weakened or torn soft tissue and can be integrated into surgeons' standard of care ACL reconstruction techniques.
PROCEDUREArthroscopic anterior cruciate ligament reconstructionAn arthroscopic anterior cruciate ligament reconstruction is performed using standard surgical procedure.

Timeline

Start date
2025-04-08
Primary completion
2030-06-01
Completion
2030-06-01
First posted
2025-04-29
Last updated
2026-04-14

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06948591. Inclusion in this directory is not an endorsement.